Lv1
40 积分 2025-07-10 加入
Drug-Drug Interaction of the Sodium Glucose Co-Transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data
2个月前
已完结
A Disproportionality Analysis of Drug–Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS)
2个月前
已完结
Levetiracetam Interaction with Direct Oral Anticoagulants: A Pharmacovigilance Study
2个月前
已完结
Concomitant use of low molecular weight heparin mitigates bortezomib-induced peripheral Neuropathy: Analysis of the FDA adverse event reporting system
2个月前
已完结
Ceritinib–ibuprofen synergistic hepatotoxicity: Insights from real-world data and liver organoid models
2个月前
已完结
Unraveling sex-related cardiovascular toxicity of immune checkpoint inhibitors by pharmacovigilance and single-cell transcriptomic analysis
2个月前
已完结
Real-world safety of satralizumab in neuromyelitis optica spectrum disorder: a FAERS-based risk stratification study
2个月前
已完结
Drug-Induced Acute Pancreatitis: A Real-World Pharmacovigilance Study Using the FAERS Database
2个月前
已完结
Safety Assessment of Budesonide/Formoterol: Real-World Pharmacovigilance Analysis Using the FAERS, JADER, and CVAR Databases
4个月前
已完结
Disproportionality Analysis of Dermatologic Adverse Events Associated with Nirogacestat: Insights from the FDA Adverse Event Reporting System (FAERS)
8个月前
已完结
皖公网安备34019202002308
